Premium
GE HealthCare Technologies Inc (GEHC)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Mr. Kevin A. LoboIndependent Director | 10,00k | 641,80k | Achat | 64,18 | 14,36k | 229,20% |
| 2026-05-15 | Ms. Jeannette BankesPresident & CEO of Patient Care Solutions | -5,54k | 346,88k | Sale to Issuer | 62,67 | 38,36k | -12,61% |
| 2026-05-12 | Dr. Rodney F. HochmanLead Independent Director | 1,62k | 100,36k | Achat | 62,03 | 21,50k | 8,14% |
| 2026-05-08 | Ms. Phoebe L. Yang WatkinIndependent Director | 1 000,00 | 63,01k | Achat | 63,01 | 1 000,00 | - |
| 2026-05-06 | Mr. H. Lawrence CulpIndependent Chairman | 80,81k | 5,00M | Achat | 61,88 | 492,17k | 19,64% |
| 2026-05-06 | Mr. William J. StrombergIndependent Director | 1 000,00 | 61,69k | Achat | 61,69 | 1 000,00 | - |
| 2026-05-01 | Mr. James K. SaccaroVP & CFO | 3,31k | 200,59k | Achat | 60,60 | 52,81k | 6,69% |
| 2026-04-30 | Mr. Frank R. JimenezGeneral Counsel & Corporate Secretary | 1,75k | 105,79k | Achat | 60,45 | 62,62k | 2,87% |
| 2026-04-30 | Mr. Peter J. ArduiniPresident, CEO & Director | 4,17k | 249,83k | Achat | 59,93 | 130,58k | 3,30% |
| 2026-02-12 | Mr. Kevin Michael O’NeillPresident & CEO of Pharmaceutical Diagnostics | -3,26k | 258,27k | Sale to Issuer | 79,20 | 18,22k | -15,18% |
| 2026-02-12 | Mr. George Andrew NewcombController & CAO | -802,00 | 63,52k | Sale to Issuer | 79,20 | 7,00k | -10,28% |
| 2026-02-12 | Mr. Roland RottInitié | -3,94k | 312,29k | Sale to Issuer | 79,20 | 18,48k | -17,59% |
| 2026-02-12 | Mr. Philip D. RackliffePresident & CEO of Advanced Imaging Solutions (AIS) | -1,17k | 92,98k | Sale to Issuer | 79,20 | 9,62k | -10,88% |
| 2026-02-12 | Dr. Taha Kass-HoutChief Science & Technology Officer | -7,79k | 616,73k | Sale to Issuer | 79,20 | 57,23k | -11,98% |
| 2026-02-12 | Mr. Frank R. JimenezGeneral Counsel & Corporate Secretary | -8,36k | 661,87k | Sale to Issuer | 79,20 | 60,87k | -12,07% |
| 2026-02-12 | Mr. Peter J. ArduiniPresident, CEO & Director | -33,45k | 2,65M | Sale to Issuer | 79,20 | 126,41k | -20,92% |
| 2026-02-12 | Mr. James K. SaccaroVP & CFO | -8,57k | 678,74k | Sale to Issuer | 79,20 | 49,50k | -14,76% |
| 2026-02-01 | Mr. Kevin Michael O’NeillPresident & CEO of Pharmaceutical Diagnostics | -462,00 | 36,48k | Sale to Issuer | 78,97 | 14,54k | -3,08% |
| 2026-02-01 | Mr. Philip D. RackliffePresident & CEO of Advanced Imaging Solutions (AIS) | -189,00 | 14,93k | Sale to Issuer | 78,97 | 7,64k | -2,42% |
| 2026-02-01 | Dr. Taha Kass-HoutChief Science & Technology Officer | -847,00 | 66,89k | Sale to Issuer | 78,97 | 41,68k | -1,99% |
| 2026-02-01 | Mr. George Andrew NewcombController & CAO | -108,00 | 8,53k | Sale to Issuer | 78,97 | 5,28k | -2,00% |
| 2026-02-01 | Mr. Roland RottInitié | -558,00 | 44,07k | Sale to Issuer | 78,97 | 14,54k | -3,70% |
| 2026-02-01 | Mr. Frank R. JimenezGeneral Counsel & Corporate Secretary | -947,00 | 74,78k | Sale to Issuer | 78,97 | 47,15k | -1,97% |
| 2026-02-01 | Mr. James K. SaccaroVP & CFO | -948,00 | 74,86k | Sale to Issuer | 78,97 | 35,46k | -2,60% |
| 2026-02-01 | Mr. Peter J. ArduiniPresident, CEO & Director | -3,21k | 253,49k | Sale to Issuer | 78,97 | 84,95k | -3,64% |
| 2025-09-11 | Mr. Roland RottInitié | 721,00 | 40,04k | Derivative Exercise and Retained Stock | 51,67 - 57,74 | 13,98k | 5,44% |
| 2025-09-11 | Mr. Roland RottInitié | -4,62k | 95,71k | Derivative Exercise and Sale | 51,67 - 76,68 | 13,98k | - |
| 2025-09-01 | Mr. Kenneth R. StacherskiChief Global Supply Chain & Service Officer | -892,00 | 65,77k | Sale to Issuer | 73,73 | 19,53k | -4,37% |
| 2025-09-01 | Mr. Adam Y. HoltonCPO | -464,00 | 34,21k | Sale to Issuer | 73,73 | 987,00 | -31,98% |
| 2025-09-01 | Dr. Taha Kass-HoutChief Science & Technology Officer | -2,90k | 213,60k | Sale to Issuer | 73,73 | 39,22k | -6,88% |
| 2025-09-01 | Mr. Philip D. RackliffePresident & CEO of Advanced Imaging Solutions (AIS) | -1,89k | 139,42k | Sale to Issuer | 73,73 | 7,37k | -20,42% |
| 2025-09-01 | Mr. Roland RottInitié | -1,83k | 135,22k | Sale to Issuer | 73,73 | 13,26k | -12,15% |
| 2025-09-01 | Mr. Frank R. JimenezGeneral Counsel & Corporate Secretary | -3,08k | 227,01k | Sale to Issuer | 73,73 | 44,97k | -6,41% |
| 2025-09-01 | Mr. James K. SaccaroVP & CFO | -3,24k | 238,74k | Sale to Issuer | 73,73 | 33,43k | -8,83% |
| 2025-09-01 | Mr. Peter J. ArduiniPresident, CEO & Director | -11,35k | 836,54k | Sale to Issuer | 73,73 | 77,45k | -12,78% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
